Imagine a man, once on death's doorstep, now celebrating a quarter-century of life. This isn't just a medical success story; it's a testament to the resilience of the human spirit and the incredible advancements in HIV treatment. Recently, I had the privilege of sharing cake with a patient at our HIV and infectious diseases clinic in Mumbai. This wasn't just any celebration; it marked 25 years since he arrived at our clinic in a near-comatose state, barely clinging to life. Back in 1999, his prognosis seemed bleak. Today, at 60, he stands as a living example of hope.
At 35, he was referred to me by Dr. Shyam Pophale. His health had rapidly deteriorated, starting with unsteadiness and slurred speech, eventually leading to a complete loss of responsiveness. He had recently tested positive for HIV, and his situation was complicated by his young, HIV-negative wife and their two-year-old daughter.
The tests at our clinic painted a grim picture. His CD4 count, a crucial indicator of immune strength, was a mere 12 (a healthy range is between 500 and 1600), and his viral load exceeded 2.1 million copies per milliliter of blood. His immune system was on the brink of collapse, and the virus was multiplying unchecked.
Initially, we suspected common late-stage HIV infections like toxoplasmosis or tubercular meningitis, given his neurological symptoms. But here's where it gets controversial... he lacked the hallmark headache associated with these illnesses. An MRI revealed lesions in his brain's white matter, pointing to Progressive Multifocal Leukoencephalopathy (PML), a rare and often fatal condition.
PML is caused by the JC virus, which typically lies dormant. However, when the immune system is severely compromised, it can attack the brain, destroying its protective covering and causing severe neurological damage.
At the time, diagnosing PML relied heavily on clinical judgment, as advanced tests like PCR were unavailable. He was admitted to Bombay Hospital under the care of Dr. BS Singhal, a renowned neurologist. Unlike many infections, PML had no direct cure. Our only hope was to aggressively treat his HIV and manage his symptoms, giving his immune system a chance to recover. We prescribed a combination of Indinavir, Zidovudine, and Lamivudine – antiretroviral drugs (ARVs) known to effectively penetrate the brain.
ARVs don't directly kill HIV; they prevent it from multiplying. This allows the immune system to rebuild and fight off infections like PML. We were honest with the family, acknowledging the slim chances of survival, yet they held onto hope.
And this is the part most people miss... Within three weeks, a remarkable turnaround began. His speech returned, albeit with a stammer, and his mobility gradually improved. He started interacting with his family again, a process that took months of dedicated care and support.
What truly resonates with me is the human story intertwined with this medical triumph. The patient, once considered beyond help, continues to live a fulfilling life thanks to consistent care. Sadly, his wife, who remained HIV-negative, passed away from a heart condition. However, their daughter, who was just a toddler when I first met her, is now 28 and recently married.
For those wondering how his wife remained uninfected, it's important to understand that transmission is not guaranteed. With careful precautions and a bit of luck, some spouses of HIV-positive individuals, even those not yet on treatment, do not contract the virus.
Their daughter also remained uninfected. With modern HIV treatment, known as ART, a person living with HIV can achieve an undetectable viral load. The principle of 'Undetectable = Untransmittable' (U=U) means the virus cannot be passed on to a partner or unborn child.
Over the years, we've treated nearly 50 PML cases among the 7,500 people living with HIV under our care. Some patients didn't survive, particularly when Indinavir, a crucial HIV drug, became unavailable.
However, many defied the odds, and today, newer HIV medications that are even more effective at reaching the brain offer even greater hope. With early diagnosis and treatment, people with HIV can now expect to live near-normal lifespans.
But what if his wife had been more vigilant about her health? This story underscores the importance of medical vigilance extending beyond the patient to the entire family. It's a poignant reminder that those close to individuals living with HIV should also prioritize their health.
Dr. Ishwar Gilada, a consultant in HIV, STIs, and infectious diseases, and president emeritus of the AIDS Society of India, shared this story.
What are your thoughts? Do you think the medical community is doing enough to promote family health awareness in cases of HIV? Share your opinions in the comments below!
